Cargando…
Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy
OBJECTIVE: Immunity and inflammation are key mediators of carcinoma development, invasion and metastasis. However, it remains unknown whether the systemic immune-inflammation index (SII) can be used as a prognostic indicator for cholangiocarcinoma. In this study, we investigated the association and...
Autores principales: | Li, Jinyu, Gao, Long, Liu, Tianci, Feng, Duiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815453/ https://www.ncbi.nlm.nih.gov/pubmed/36620590 http://dx.doi.org/10.3389/fonc.2022.1038759 |
Ejemplares similares
-
ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022) -
Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022) -
CT-Based Radiomics Analysis for Noninvasive Prediction of Perineural Invasion of Perihilar Cholangiocarcinoma
por: Zhan, Peng-Chao, et al.
Publicado: (2022) -
Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021) -
Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study
por: Yang, Po-Chih, et al.
Publicado: (2021)